TNFSF10 and neoplasm: Recently CD40 ligand (mCD40L) in combination with CRAD-TRAIL induced immune activation of dendritic cells DCs, B cells, and tumor-infiltrating T cells along with upregulation of DRs on the tumors thus elucidating a novel strategy for oncolytic adenovirus-mediated solid tumor immunotherapy [244,245].